|
|
|
|
|
FREMONT, CA, 2023年3月28日 - (亞太商訊) - Q'Apel Medical Inc. was granted the CE Mark under MDR for Walrus, their U.S. market-leading Balloon Guide Catheter (BGC) utilized in treating patients suffering an acute ischemic stroke. The Walrus BGC has been utilized by Neuro Interventional physicians since 2019 and has successfully treated over 20,000 patients in the United States.
The Walrus BGC is a unique development in the field of Mechanical Thrombectomy procedures. It provides physicians with not only the known benefits of BGC use clinically, but unique to Walrus, superior ease of use in preparation in these urgent procedures. Importantly, Walrus enables the physicians to navigate the catheter into a more distal location easily and safely compared to other systems, which is associated with improved patient outcomes from stroke.
"The anticipation of Walrus in our international markets has been enormous, and we look forward to the same performance and loyalty around Walrus we have been fortunate to experience in the United States," said King Nelson, Q'Apel Medical's CEO.
"We are thrilled to be entering the EU and other international markets with Walrus and providing more physicians in more countries the unparalleled performance of our flagship catheter. This CE Mark certification represents a significant growth milestone for Q'Apel Medical providing access to new markets," commented Jodie Fam, Chief Marketing Officer & GM International.
About Q'Apel Medical
Q'Apel Medical designs highly innovative technologies for neurovascular interventions and unmet clinical needs. Q'Apel's portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. By blending flow control, trackability, support, and access into one revolutionary solution, Walrus offers truly unmatched functionality. The Wahoo Hybrid Access System and Armadillo Radial Access System are dual-mode catheters and part of the SelectFlex(TM) Family of Neurovascular Catheters. These devices feature two distinct operational modes, allowing physicians to easily switch modes at any point during a clinical case and reducing the need for multiple catheters in challenging procedures.
Media Contact:
Jodie Fam
415 244 9885
+44 7500702108
jfam@qapelmedical.com
info@qapelmedical.com
www.qapelmedical.com
Contact Information
Jodie Fam
Chief Marketing Officer & GM International
jfam@qapelmedical.com
4152449885
SOURCE: Q'Apel Medical Inc.
話題 Press release summary
部門 制药及生物技术, 健康与医药
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network
|
|
|
|
|
|
 |
|
Latest Press Releases
Business delegation visits Kazakhstan to strengthen economic and trade cooperation
June 2, 2026, 22:23 HKT/SGT
|
|
|
How to Select the Suitable Personal Loan Options in Singapore for Home Renovations
June 2, 2026, 21:46 HKT/SGT
|
|
|
GMG Applies for Additional Environmental Approvals to Produce Graphene in USA
June 2, 2026, 19:59 HKT/SGT
|
|
|
Doubleview Appoints Canaccord Genuity as Financial Advisor in Connection with a Formal Strategic Review Process
June 2, 2026, 17:59 HKT/SGT
|
|
|
52TOYS Secures Strategic Position in Hong Kong-Macau Core Hub with Grand Opening of Hong Kong International Airport Store
June 2, 2026, 17:41 HKT/SGT
|
|
|
uSMART Operated the First uSMART Cafe in Kai Tak, Serves the Local Community, Combining Smart Finance with Lifestyle
June 2, 2026, 16:22 HKT/SGT
|
|
|
Mint and Rice Robotics Launch Joint Venture to Expand AI Companion Robot Business with HK$15M in funding
June 2, 2026, 14:20 HKT/SGT
|
|
|
DST Files for Hong Kong IPO: Asset Operation Management Services and Ecosystem Synergy Driving Growth
June 2, 2026, 10:44 HKT/SGT
|
|
|
Graid Technology Launches VROC(TM) by Graid Technology with 24-Month Roadmap and Tier 1 OEM Support
June 2, 2026, 08:00 HKT/SGT
|
|
|
AibleClaw Uses NVIDIA Cloud Functions to Bring Up to a 200X TCO Advantage to Long-Running Enterprise AI Agents
June 2, 2026, 00:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
